We provide representative gel analyses of patients with COVID-19 having increased VWF concentrations and antibodies to ADAMTS13, critically ill patients without COVID-19 and patients with acute TTP. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.